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The mononuclear and polymorphonuclear cells ofthe body have the capacity to
bind, phagocytose, and ultimatelydestroy antibody-coatedparticlessuch as bacteria
bya series oflinked molecular processes that initially involvethe plasma membrane
Fc receptors for IgG (FcyR). Our understanding ofthese FcyR-mediated processes
is rudimentary. We know that first the Ig-coated particles bind to the surface ofthe
cell by interaction with FcyR. By poorly understood means, crosslinking of these
receptors signals the movement oflamellar membrane and underlying cytoplasm
around the particle until it is eventually engulfed, whereupon the particle is trans-
ported intracellularly to lysosomes for eventual degradation (1, 2).
Attempts to define the molecular details of these processes have in recent years
focussed on the structure ofthe FcyR. Considerable structural information is now
available. We now know that phagocytic cells ofman bear three distinct classes of
FcyR. Althoughthey are all members ofa group ofclosely related molecules within
the Ig gene superfamily, these receptors can be distinguished from one another on
the basis of size, primary structure, affinity for ligand, to some extent specificity
for ligand, and mAb reactivity. Within each of the three classes of receptors, it is
clearthat subclasses exist, as evidenced by studies ofthe cDNA sequences (recently
reviewed in references 2, 3).
Whether all ofthese classes ofFcyR, two or three ofwhich are expressed on all
phagocytic cells, are capable ofmediating phagocytosis has been the focus ofmuch
recent attention (4-6). Our strategy has been to design immune complex probes
specific for each of the receptor classes. Attempts using immune complexes of in-
dividual IgG subclasses have met with only partial success because the specificity
ofthesereceptor classes forsubclasses ofIgG ligand is relative rather than absolute.
Likewise, approaches usingFcyR class-specific mAbs to inhibit the bindingofIgG
immune complexes to one or more receptor classes have not been definitive, pre-
sumably because the avidity ofa large immune complex for a cell surface may out-
weigh the affinity of mAbs for the FcyR under study. Instead, we have evaluated
FcyR class-specificphagocytosis bypresenting adherentphagocytic cellswitherythro-
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cytes coated with anti-FcyR mAbs, thereby attempting to crosslink FcyR and stimulate
phagocytosis.
We find that FcyRI and FcyRII on all cell types tested, and FcyRIII on mononuclear
phagocytes, are capable ofmediating phagocytosis. However, FcyRIII on polymor-
phonuclear leukocytes (PMN)' under the conditions of these experiments appears
unable to generate a phagocytic signal. FcyRIII on PMNs, it should be noted, is
not a membrane-spanning molecule but rather is linked to the outer leaflet of the
plasma membrane by a glycosyl-phosphatidylinositol moiety (7-9).
Materials and Methods
Chemicals and Reagents.
￿
Percoll was obtained from Pharmacia Fine Chemicals, Uppsala,
Sweden; Ficoll-Hypaque (Histopaque-1077), BSA, fraction V, human serum albumin (HSA),
and aprotinin from Sigma Chemical Co., St. Louis, MO; Mono-Poly Resolving Medium
from Flow Laboratories, McLean, VA; IFN-y from Genentech, South San Francisco, CA;
ox erythrocytes (OE) and FCS from Colorado Serum Co., Denver, CO; N-succinimidyl-3-(2
pyridyldithiol) propionate (SPDP) from Pharmacia Fine Chemicals; N-succinimidyl-S-
acetylthioacetate (SATA) from Calbiochem-Behring Corp., LaJolla, CA; HBSS and RPMI
1640 medium from Whittaker 1VI. A. Bioproducts, Inc., Walkersville, MD; Macrophage colony-
stimulating factor (M-CSF) (10) from Cetus Corp., Emeryville, CA; Penicillin, streptomycin,
and Medium 199 from Gibco Laboratories, Grand Island, NY; dimethyl formamide (DMF)
from Pierce Chemical Co., Rockford, IL; and Diff-Quik from American Scientific Products,
McGaw Park, IL. A balanced salt solution (BSS) was prepared as described (11). Terasaki
plates were obtained as Microtest Plates from Walter Sarstedt, Inc., Princeton, NJ. FITC
anti-murine Ig was obtained from Cappel Laboratories, West Chester, PA. PBS contained
8 mM phosphate, 137 mM NaCl, 2.7 mM KCI, 0.5 MM MgC12 , and 0.9 mM CaC12.
PBS/BSA/Az consisted of PBS plus I mg/ml BSA and 0.2% NaN3 . IgG and Fab or F(ab')2
fragments of the following mAbs were obtained from Medarex, Inc., West Lebanon, NH;
mIgG1 anti-FcyRI mAb 32, mIgG26 anti-FcyRII mAb IV3, mIgGI anti-FcyRIII mAb 3G8.
The fragments contained 41% intact IgG by gel filtration analysis. Murine myeloma pro-
teins ofthe IgGI (MOPC 21) and IgG2b (MOPC 141) subclasses and mIgG26 anti-(32 micro-
globulin mAb BBMI, mIgG2b anti-complement receptor 3 mAb OKMI were purified by
ion-exchange chromatography from ascites fluid obtained from American Type Culture Col-
lection, Rockville, MD. Human IgG was purified from pooled human serum by salt precipi-
tation and ion-exchange chromatography. Rabbit anti-OE IgG was obtained from Organon
Teknika Corp., Westchester, PA. F(ab')z fragments of anti-OE were prepared by pepsin
cleavage, were separated by gel filtration, and were adsorbed with protein A-agarose to re-
move residual IgG. Buffy coat preparations from cytophoresis packs were obtained from normal
subjects by the Franklin County American Red Cross, Columbus, OH .
Preparation ofHeteroantibodies.
￿
Heteroantibodies of F(ab')2 32, Fab IV.3, F(ab')2 3G8, Fab
OKMI, or Fab BBMI covalently linked to F(ab')2 anti-OE were made by the method ofKar-
povsky et al. (12). In brief, Fab or F(ab')2 fragments of mAbs at 1-2 mg/ml in PBS containing
5 mM EDTA were incubated with a threefold molar excess of SPDP for 2 h at 18°C. F(ab')2
anti-OE at 6 mg/ml in PBS/EDTA were incubated with a threefold molar excess of SATA
in DMF for 1 h at 18°C and were gel filtered over a G25~Sephadex column equilibrated with
PBS/EI7I'A. Antibodies thus derivatized were dialyzed overnight in degassed PBS/EDTA under
N2. SATA-F(ab')2 anti-OE was deacetylated using 50 mM hydroxylamine for 1 h at 18°C,
and was gel filtered through a a PBS/EDTA-equilibrated G25 Sephadex column. Equimolar
amounts of SATA-F(ab')2 anti-OE and SPDP-Fab or -F(ab')2 fragments of mAb were immedi-
' Abbreviations used in this paper: AI, adherence index; BSS, balanced salt solution; CR3, complement
receptor 2; FcyR, Fc receptor(s) for IgG; HSA, human serum albumin; M-CSF, macrophage CSF;
OE, ox erythrocytes; PI, phagocytic index; PMN, polymorphonuclear leukocytes; SATA, N-succinimidyl-
S-acetylthioacetate; SPDP, N-succinimidyl-3-(2-pyridyldithiol).ANDERSON ET AL.
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ately mixed and incubated at 1$'C for 4 h, after which crosslinking was terminated with
iodoacetamide, added to a 10% molar excess over thiol groups. Heteroantibodies, dialyzed
into PBS, were used at a concentration of 0.7-1.45 OD280 U/1111-
Cells.
￿
Peripheral blood, obtained by venipuncture from normal human volunteers, was
drawn into heparin-filled syringes and was separated into its cellular components on Mono-
Poly Resolving Medium. PMN were harvested as a discrete band. In some experiments PMN
were cultured overnight at 2 x 106/ml in Medium 199, 20% heat-inactivated FCS, r.-
glutamine, with IFN-,y (300 U/ml). Before use PMN were suspended at 2 x 106/ml in PBS
supplemented with dextrose (3 mM), HSA (0.5 mg/ml), and aprotinin (0.3 U/ml) (PBS-HAG).
Monocytes were prepared by the method ofWright (13). Briefly, mononuclear cells from buffy
coats of cytophoresis packs were centrifuged on Ficoll-Hypaque and the interface layer was
collected. The cell concentration was adjusted to 2-4 x 107/ml in RPMI 1640 medium con-
taining 10% normal human serum. 5 ml of mononuclear cells were layered onto 37.7 ml
of Percoll adjusted to isotonicity and the gradients were promptly centrifuged in a swinging
bucket rotor at 1,000 g for 20 min at 5°C . The top of two thick hazy bands contained mono-
cytes. Purified monocytes were washed in RPMI 1640, were suspended at 106/ml in RPMI
1640 containing 14% normal human serum, and were either used fresh or were cultured
in teflon beakers with M-CSF (1,000 U/ml). In some experiments monocytes were purified
by adherence to fibronectin-coated tissue culture flasks as described (14). Human alveolar
macrophages (390 pure) from nonsmoking normal volunteers were obtained by bronchoal-
veolarlavage (BAL) using standard methods (15). Before use the monocytes and macrophages
were suspended at 2 x 106/ml in BSS containing 5 mM Mg2' and 5% FCS.
Adherence and Phagocytosis Assays.
￿
OE were coated with antibodies (EHA) by incubating
heteroantibbdies for 2 h at 21'C with an equal volume of a 50% suspension of OE in PBS.
Mock-coated erythrocytes were carried through the entire procedure without the addition
of antibody. OE were incubated in similar fashion with a subagglutinating concentration of
rabbit IgG anti-OE to prepare IgG-opsonized OE (EA). The coated erythrocytes were then
washed three times and resuspended at 1% (vol/vol) in PBS. Phagocytosis and adherence
assays usingOE targets were performed by the method of Wright (13). Wells of Terasaki plates
were coated with HSA (10 it] of 1 mg/ml PBS solution) by incubation for 60 min at 21'C
and were washed with PBS. Phagocytes were allowed to adhere to the well bottoms by in-
cubating 10 p,l of a phagocyte suspension in the wells for 60 min at 37oC. Nonadherent cells
were washed away and 10 141 ofan ox erythrocyte suspension were added to wells. In the inhi-
bition experiments mAbs (intact IgG, Fab, or F(ab')2 fragments) were added along with
phagocytic targets. Plates were incubated 30 min at 37oC in a humidified incubator, were
again washed in PBS, and were then fixed with 217o glutaraldehyde for analysis ofadherence.
In separate plates phagocytosis was analyzed after dipping plates in water to lyse adherent
OE before fixation with glutaraldehyde.
Phagocytosis and adherence were scored by evaluating 200 phagocytes microscopically for
the number of internalized or adherent erythrocytes at x600 magnification using a phase
contrast water immersion lens. The data are expressed as a phagocytic index (PI) or an ad-
herence index (AI), the number, respectively, of phagocytosed or adherent erythrocytes per
100 leukocytes. Unless stated otherwise, the sample mean and standard error of the mean
for three or more similar experiments are expressed.
In some experiments preparations of heteroantibody-coated ox erythrocytes used in Ter-
asaki (adherent) plate assays were tested simultaneously in an assay that involved centrifuga-
tion of the erythrocytes and phagocytes into a pellet before the 37oC incubation (16). Briefly,
10' erythrocytes and 106 PMN in 200 /Al RPMI 1640 containing 20% FCS were centrifuged
into a pellet at 44 g and were incubated for 1 h at 37oC. Cytocentrifuge preparations were
stained with DiH=Quik and PMNs were scored microscopically for internalized OE.
Flow Cytometry.
￿
To quantify and compare the amounts of murine mAbs bound to the
heteroantibody-coated erythrocytes, 1.5 ul ofantibody-coated erythrocytes prepared as above
were pelleted and resuspended in 20 Al FITC-anti-mIgG. The mixtures were incubated 2 h
at VC, were washed three times in PBS/BSA/Az, and were fixed in 1% paraformaldehyde.
Single cell fluorescence was analyzed on an EPICS C flow cytometer (Coutler EPICS Divi-
sion, Hialeah, FL) as previously described (17).1336
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Results
Receptor Specificity ofAntibody-coated Erythrocytes.
￿
Ourmethod for assessingthe ca-
pacity ofeach ofthe three classes of FcyR on phagocytic cells to mediate phagocy-
tosis was briefly the following: OE were coated with anti-FcyR mAbs by incubating
them with heteroantibodies (18) consisting of F(ab')2 fragments ofanti-OE covalently
linked to Fab or F(ab')2 fragments ofanti-FcyR mAb specific for each ofthe three
FcyR classes, FcyRI (mAb 32), FcyRII (mAb IV3), or FcyRIII (mAb 3G8). These
antibody-coated erythrocytes were then incubated with phagocytes adherent to
albumin-coatedTerasaki wells andthe extent ofphagocytosis was scored microscop-
ically and expressedas a phagocytic index (PI), largelyby the method ofWright (13).
We first evaluated whether each of the anti-Fc-yR-coated erythrocytes (referred
to as E32, EIV3, and E3G8) was a specific probe for the appropriate FcyR by per-
formingthe phagocytosis assaywithcultured monocytes inthe presence ofsaturating
concentrations ofvariousanti-FcyR mAbs. Thesecells, which express all three classes
of FcyR, were observed to bind (not shown) and to phagocytose vigorously (Fig.
1) erythrocytes coated with mAbs to all three FcyR; specifically, in several experi-
ments the PI mean t SEM for E32 was 181 t 91, for EIV3 was 232 t 81, and
for E3G8 was 108 t 29 (Fig. 1). Only in the presence ofthe homologous anti-FcyR
mAb, at saturating concentrations, was phagocytosis inhibited, as seen in Fig. 1,
withmAb 32 inhibiting E32 phagocytosis 81% t 5, mAbIV3 inhibiting EIV3 phago-
cytosis95% t 3, and mAb 3G8 inhibiting E3G8 phagocytosis 97% f 2 in aseries
ofrepetitive experiments. mAbsdirected against different classes ofFcyR ormurine
IgGofthe same subclasses as the anti-FcyR mAbs, or human IgG, all at concentra-
tions of 50 ftg/ml, were unable to inhibit phagocytosis (Fig. 1).
Specificity of these targets is also indicated by the observations (Fig. 2) that the
antibody-coated targets failed to bind to cells that did not express the appropriate
receptor. Forexample, E32 wasnotcapableofbindingto PMNsthat have been shown
tobe devoid ofsignificant numbers ofFcyRI. Further, E3G8 did not bind to freshly
purified monocytes that bear little or no FcyRIII (19, 20; Anderson, C. L., R. J.
Looney, D. J. Culp, D. H. Ryan, H. B. Fleit, M.J. Utell, M. W. Frampton, P Man-
ganiello, and P. M. Guyre, manuscript submitted for publication).
Phagocytic Capacity ofFcyR Classes Expressedby Several Cell Types.
￿
The abilityoffive
different types of phagocytic leukocytes to phagocytose by means of the three dis-
tinct FcyR classes was evaluated by incubating adherent phagocytes with erythro-
cytes coated with anti-FcyR mAbs. The phagocytic cells evaluated were freshly iso-
lated monocytes that express FcyRI and FcyRII (21); cultured monocytes, alveolar
macrophages, and PMNs cultured in IFN-y that express all three classes (20, 22;
Anderson et al., manuscript submitted for publication); and freshly isolated PMNs
thatdisplayFcyRII and FcyRIII (17). Fig. 2 presentsasummary ofthe results. Freshly
isolated monocytes thatbear FcyRI and FcyRII were capable ofbinding andphago-
cytosing E32 andEIV3, whereasE3G8was neitherboundnorphagocytosed. Mono-
cytes that had been cultured for several days such that they expressed FcyRIII in
addition to FcyRI and FcyRII were capable ofbinding and phagocytosing all three
anti-FeyR-coated erythrocytes. Likewise, alveolar macrophages that bore all three
FcyR classes bound and phagocytosed the erythrocyte probes for all three classes
of receptor. In contrast, polymorphonuclear leukocytes behaved somewhat differ-
ently: freshly purified PMNsthatbear FcyRII andFcyRIII were capable ofbindinga O
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Specificity controls for phagocytosis of anti-FcyR mAb-coated erythrocytes. Cul-
tured monocytesadherent to albumin-coated Terasaki wellswere incubatedfor60 minwith anti-
FcyR mAb-coated erythrocytes in the presence ofanti-FcyR InAbs and antibodies of the same
IgG subclass (all at 50 kg/ml). Unphagocytosed erythrocytes were lysed, andthe extent ofphago-
cytosis, enumerated by phasecontrast microscopy, wasexpressed as aphagocytic index (PI). The
percent inhibition of phagocytosis was calculated by the formula [1-(PLO x 100 where Iis the
PI observed in thepresence ofinhibitory protein and Uis the PI observed in the presence only
of albumin-containing medium. The mean andSEM of three to four observations in most cases
are plotted. mAbs 32, IV3, and 3G8 recognize monocyte FcyRI, II, and III, respectively.
both EIV3 and E3G8, but onlythe probe for FcyRII was phagocytosed; E3G8were
not phagocytosed. Likewise, PMNs cultured overnight in IFN-'Y such that they ex-
press all three FcyR classes bound the probes for all three FcyR but were capable
ofphagocytosingonlythoseforFcyRI andFcyRII. Aswith freshPMNs, IFN-cultured
PMNs failed to phagocytose E3G8. Erythrocytes coated with mAbs against either
i82 microglobulin (mAb BBMI) or complement receptor 3 (CR3) (mAb OKM1)
were bound by all ofthesecell types but were not phagocytosed, while mock-coated
erythrocytes were neither bound nor phagocytosed.
Simultaneous Analysis ofE3G8Phagocytosis byPMNandCulturedMonocytes.
￿
Considering
the possibility that different lots ofE3G8 had coincidentally led to the observations
noted in Fig. 2, we performed two experiments in which IFN-PMN and cultured
monocytes adherentto wells ofthe sameTerasaki plate were incubatedwiththe same
preparation of E3G8. As seen in Fig. 3, erythrocytes coated with mAbs to all three
FcyR classes bound to both cell types as did the erythrocytes coated with a mAb
againstan irrelevant antigen(either02 microglobulin orCR3). However, E3G8was
phagocytosed only by cultured monocytes and not by interferon-cultured PMNs.
Again, neither cell type phagocytosed erythrocytes coated with BBMI or OKMI,
and mock-coated erythrocytes were neither bound nor phagocytosed.
RelativeAmounts ofanti-FcyR mAb on Erythrocytes.
￿
Despite the fact that E3G8 was
phagocytosed by mononuclearphagocytes, itseemed possible that thefailure ofE3G81338
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Adherence andphagocytosis ofanti-FcyR mAb-coated erythrocytes. Freshly purified
peripheral blood monocytes (Monos), monocytes cultured for severaldays in vitro(CultMonos),
freshly isolated polymorphonuclear leukocytes (PMN), PMN cultured overnight in IFN--Y
(PMN-IFN), and alveolar macrophages (Alv Macs) that were adherent to albumin-coated Ter-
asaki wells were incubated for 30 min with erythrocytes coated with heteroantibodies prepared
from anti-FcyRmAbs (those used in Fig. 1, designated E32, EIV3, andE3G8), with erythrocytes
coated with heteroantibodies prepared from mAbs recognizing determinants that were likely not
to mediate phagocytosis (OKMI anti-CR3 and BBMI anti-02 microglobulin, both designated
EC, C for"control"), andwith mock-coated erythrocytes (E). Unphagocytosed erythrocytes were
lysedby hypotonic shock, and the extent of phagocytosis, enumerated by phasecontrast micros-
copy, was expressed as a phagocytic index (PI). In separate Terasaki plates containing cells that
were not subjectedto hypotoniclysis, theadherenceindex (AI) wasenumerated. The meansand
SEM of four to five observations for each cell type are plotted.
to be phagocytosed by PMNs could bedue to inadequatequantities ofmAbs bound
to the erythrocyte. Wetherefore compared intwo experiments not shown theamounts
of murine antibody bound to the surface of E32, EIV3, E3G8 by indirect im-
munofluorescence using FITC-anti-murine Ig and flow cytometry. The amount of
murine antibody on the E3G8 cells was appreciably greaterthan on any oftheother
probes, two ofwhich (E32 and EIV3) were vigorously phagocytosed. This finding
would indicate that the failure of E3G8 phagocytosis by PMNs was not a conse-
quence of inadequate coating of mAb 3G8 on the erythrocyte surface.
RelativeExpression ofFcyRonPhagocytes.
￿
Even though FcyRI1Iappears tobe more
highly expressed on PMN and IFN-PMN than either FcyRI or FcyRII (5, 17, 20),
we considered thepossibility thatunder theconditions ofour experimental protocol
FcyRIIIhadbeenlost from thecell surface ofPMN orIFN-PMN such thatbinding
and subsequent phagocytosis of E3G8 were impeded. However, as can be seen in
Fig. 2, the AI ofE3G8 to PMN and IFN-PMN equaled or exceeded the AI of all
oftheother antibody-coated erythrocytes including EIV3, which were phagocytosed
by both ofthese cells and E32 which were phagocytosed by IFN-PMN. Moreover,
the AI of E3G8 exceeded or was equivalent to the AI seen with EOKMI, which
also were not phagocytosed. These datawouldsuggest that theexpression ofFc7RIII
on these cellswas sufficiently preserved such that the bindingofE3G8 was not com-a
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￿
FcryRIII-mediated attachment andphagocytosis simultaneously by interferon-cultured
PMN and cultured monocytes. These experiments were performed exactly as described in the
legend to Fig. 2with the additional feature that IFN-PMNandcultured monocytes were allowed
to adhere to wells ofthe same Terasaki plate andwere presented the same lots of antibody-coated
erythrocytes. The means t the deviation from the means of two experiments are shown.
promised and could not be responsible for the failure of a phagocytic response to
this target.
Magnitude ofPhagocytosis ofAnti-FcyR-coated Erythrocytes.
￿
We attempted to quan-
tify the magnitude ofthe phagocytic response toward anti-FcyRcoated erythrocytes
by measuring simultaneously the phagocytic index of erythrocytes coated with the
more conventional ligand, rabbit IgG anti-OE antibody (EA) (Table I). In a series
of experiments the mean phagocytic index forEA ranged from 125 with monocytes
to 426with alveolar macrophages. The vigorofthephagocytic response to anti-FcyR
TABLE I
Magnitude of Phagocytosis of EHA
Erythrocytes were coated with anti-FcyR mAbs 32 or IV3 (E32 and EIV3)
or with rabbit IgG anti-OE (EA) or they were mock coated (E).
t Phagocytosis by monocytes, IFN-cultured PMNs (IFN-PMN), andalveolar
macrophages was measured as described in the legend to Fig. 2, and phago-
cytic indices (PI) were scored. For monocytes and IFN-PMN the data are ex-
pressed as the mean t the deviation from the mean of two experiments.
1339
EHA` Monocytes IFN-PMN
Alveolar
macrophages
P11
E32 54 t 4 128 285
EIV3 34 t 7 107 t 2 174
EA 125 f 26 209 t 43 426
E 0 t 0 0 t 0 01340
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coated erythrocytes never reached this magnitude, but was nevertheless substantial,
ranging from 27o 7o (forEIV3 phagocytosis bymonocytes) to 67% (forE32 phagocy-
tosis by alveolar macrophages) of the PI seen with EA.
Phagocytosis by Adherent Cells and by Meted Cells.
￿
Considering the possibility that
PMN phagocytosis of E3G8 may depend on the manner ofphysical interaction be-
tween the target and the phagocyte, or on the state of adherence ofthe phagocyte,
we compared two methods ofevaluating phagocytosis, the one described above in
Fig. 2 and another method in which opsonized erythrocytes mixed with phagocytes
were centrifuged into a pellet before a 37°C incubation (16). Three such experi-
ments are summarized in Table II. E3G8 were not phagocytosed by PMN using
either ofthe two methods, whereas these target cells were fully capable ofbinding
vigorously toPMN, the AI forE3G8in theadherence assaybeing 700 t 0, whereas
the AI for E was 17 t 1. EIV3 and EA by both methods were seen to be phagocy-
tosed by PMN, although the extent of phagocytosis was more vigorous when the
phagocytes were adherent to the Terasaki wells. Little or no phagocytosis, as ex-
pected, was seen with EOKMI and E.
Discussion
As part of a larger attempt to correlate structure of FcyR with their functions
wehave asked inthis studywhetherthe receptors ofallthreeFcyR classes arecapable
ofgenerating aphagocytic signal upon presentationoferythrocytes coated with anti-
FcyR mAbs. We found that FcyRI and FcyRII on whatever phagocytic cell they
were expressedwere capable ofmediatingphagocytosis. E32 thatbindsonlyto FcyRI
was vigorously internalized by monocytes, cultured monocytes, and IFN-PMN, all
ofwhich express this FcyR class. Likewise, EIV3 that bind FcyRII were ingested
afterpresentation to all ofthe five cell types used in this study. It is noteworthy that
thetwoFcyRthatare not constitutively expressed but rather require induction, FcyRI
on IFN-PMN and FcyRIII on cultured monocytes, also were capable ofmediating
phagocytosis.
We have considered the possibility that small amounts of contaminating intact
IgG in the heteroantibody preparations were responsible for the phagocytic signals
produced by the antibody-coated erythrocytes. One might argue that antireceptor
mAb mightligate the erythrocyte tothe phagocyte surfacewhilecontaminatingquan-
titiesofintact IgG interactedwith FcyRto generate theinternalizationsignal. How-
ever, were this scenario possible, one would have anticipated that the erythrocytes
coated with the several other mAbs with specificities for (32-microglubulin, CR3,
andFcyRIII (for PMN)would also have been phagocytosed becausetheseheteroan-
tibodies were prepared bytheidentical procedure. In fact, these targets were bound
but not phagocytosed (Fig. 2).
We found as well that FcyRIII was capable ofmediating a phagocytic signal to
E3G8, but onlyby the form ofFcyRIII expressed on cultured monocytesormacro-
phages. These two cell types readily phagocytosed E3G8. However, FcyRIII expressed
on PMN or IFN-PMN was incapable of generating a phagocytic signal upon pre-
sentation ofE3G8 even though E3G8 targets were bound vigorously. We were un-
able to attribute the phagocytic failure ofFcyRIII on PMNs to insufficient coating
ofthe 3G8 heteroantibody to target erythrocytes ortoinadequate expressionofFcyRIII
on PMNs (Fig. 2). Furthermore, the very same E3G8 targets which were phagocy-ANDERSON ET AL.
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TABLE 11
Phagocytosis by Adherent and Pelleted Cells
Phagocytosis by PMN was assessed in two ways, in the conventional manner
described in Fig. 1 in which phagocytes were adherent to Terasaki wells (ad-
herent cells), and by a different assay described in the text that entails cen-
trifugation of phagocytes and erythrocytes into a pellet (pelleted cells).
Erythrocytes were coated with anti-FcyR mAbs IV3 or 3G8 (EIV3 or E3G8),
with rabbit IgG anti-OE (EA), with anti-CR3 mAb OKM1 (EOKM1), or
they were mock coated (E).
For the adherent cells, phagocytosis and adherence were measured as described
in the legend to Fig. 2, and phagocytic and adherence indices (PI and AI) were
scored. For pelleted cells, the PI was scored as described in the text . The data
are expressed as the mean t SEM of three separate experiments. E3G8 were
capable of binding to PMN as evidenced by an adherence index on Terasaki
wells of 700 t 0, while the adherence index for E was 17 t 1 .
tosed vigorously bycultured monocytes failed to be internalized by PMNs. We are
left with theconclusion that crosslinking ofFcyRIIIon PMNs failsto invoke aphago-
cytic signal, whereas FcyRIII on mononuclear phagocytes (cultured monocytes and
alveolar macrophages) is capable of generating a phagocytic signal. We speculate
that IgG immune complexes may be bound to PMNs largely by way of FcyRIII
that appears to be the predominantly expressed class of FcyR on these cells, while
FcyRII provides the phagocytic signal. This conclusion is compatible with the ex-
periment of Huizinga et al. (6) showing that both anti-FcyRII and anti-FcyRIII
each block FcyR-mediated phagocytosis partially.
It is important to note that two forms ofFcyRIII have been described, the prod-
ucts oftwo distinct genes (9). The form on PMNs is attached to the outer leaflet
of the plasma membrane by a phosphatidylinositol-glycan moiety, while the form
on natural killer cells and on macrophages is a more conventional integral mem-
brane protein consisting ofa membrane spanning portion and a cytoplasmic do-
main (7). One might anticipate, therefore, that the PMN form ofFcyRIII, bearing
no cytoplasmic extension, might not be able to generate a transmembrane signal
thatwouldinitiateaphagocytic response. TheFcyRIIIexpressed on themononuclear
phagocytes having a cytoplasmic tail more clearly has the potential to interact with
a phagocytic signal-generating mechanism in the cell interior.
Our observation that FcyRIII on PMNs is incapable ofmediating E3G8 phago-
cytosislends support to the general notion that thePMN FcyRIII is severely limited
in its capacity to mediate the variety of biological signals stimulated by immune
complexes. There is considerable doubt that FcyRIII on PMNs is capable ofsig-
nallingtheproduction ofsuperoxide (5, 6). Furthermore, FcyRIIIon PMNsmediates
anantibody-dependent cytotoxic (ADCC) signal only withchicken erythrocytetargets,
not with nucleated cell targets (23, 24). By contrast, FcyRI and FcyRII, regardless
EHA' Pelleted cells Adherent cells
PI mean t SEM1
EIV3 51 * 24 162 t 12
E3G8 1 t 1 1 t 1
EOKMI 1 t 1 1 t 0
EA 67 t 14 271 t 13
E 0 t 0 0 t 01342
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of the cell type on which they are expressed, are capable of all immune complex-
mediated functions that have been tested, including superoxide generation (6, 17,
25, 26), ADCC against both erythrocyte and nucleated targets(23, 24), and phago-
cytosis (presented herein).
Ourobservation thatcrosslinking ofFcyRIII on PMNs fails to mediate phagocy-
tosis is in apparent conflict with thefindings ofSalmonet al. (16) whofindthat PMN
phagocytosis but not adherence ofCon A-coated erythrocytes (EconA) is inhibited
byFab fragments ofanti-FcyRIII (mAb 3G8). Theirexperimental method wassome-
what different than ours in that PMNs in our studies were adherent to albumin-
coated plastic, whereas in their experiments EconA and PMNs were centrifuged
intoa pellet before incubation at 37°C. However, duplicating their procedure using
our reagents, we were nevertheless unable to demonstrate phagocytosis ofE3G8 by
PMNswhereasEIV3 and EAwere obviouslyphagocytosed (Table II). Otherreasons
for the disparity must be sought.
Kimberly's studies suggest that crosslinking ofeither FcyRIII or FcyRIII and an
ancillary molecule isnecessary for generation ofa phagocytic signal. In light ofour
data presented herein Kimberly's observations might be interpreted as indicating
that FcyRIII crosslinking is a necessary but insufficient stimulus for the phagocy-
tosis ofEconA by PMNs. What further stimuli are required beyond FcyRIII cross-
linking needs further definition.
The work ofothers, however, is consistent with our finding that PMN FcyRIII
is limited in its capacity to signal phagocytosis. Tosi and Berger have shown that
elastase-incubated PMN havelost 85% oftheir capacity to bind 3G8yet endocytose
IgG-coated paraffin,particles normally (5).
The studiesdescribed herein ask only whether the three FcyR studied arecapable
of mediating a phagocytic signal when crosslinked; they do not ask whether these
three FcyR mediate phagocytosis when presented with physiologic ligand such as
IgG immune complexes. One might postulatethat FcyRIII onPMNsis indeed capable
ofgenerating a phagocytic signal whenpresented with physiologic ligand. This pos-
sibility is difficult to study for the reasons pointed out in the Introduction, but it
might perhaps be analyzed by downmodulating PMN FcyRII on mAb IV3-coated
surfaces and evaluating the phagocytosis of EA by FcyRII alone. Our preliminary
attempts at these experiments have been inconclusive.
One mightalsopropose thatadifferent anti-FcyRIII mAb, recognizing adifferent
epitope on FcyRIII than does mAb 3G8, would be capable ofgenerating a phago-
cytic signal upon crosslinkingofFcyRIII on PMNs. Precedence forsuch phenomena
exist formAbs against othercellsurfacemolecules (27-29); i.e., different mAbs against
the same molecule mayproducedifferent biological effects upon binding. This pos-
sibility seems unlikely given the observation (Fig. 2) that FcyRIII on mononuclear
phagocytes were capable ofmediating phagocytosis of E3G8. However, were ade-
quate quantities ofF(ab')2 or Fab fragments of other anti-FcyRIII mAbs available,
one could test this hypothesis.
Because the FcyRstudiedherein have all been shown tobe structurally pleomorphic
by recent work at the mRNA level (2, 3), our data here do not implicate FcyR of
unique molecular structure asbeing mediators ofphagocytosis. Three distinct cDNA
have been defined for FcyRl, all presumably recognizable by E32, although two
differ byonly two amino acidsintheextracellular portionwhile thethirdhas a uniqueWe are grateful to Dr. Daniel Ryan and Ms. JoEllen Bohman for help with flow cytometry
and to Dr. Steven MacEachern for statistical advice.
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cytoplasmic domain (2, 3). Which of these is expressed in the cells studied herein
is not clear. Six cDNAs, the products of three distinct genes, have been identified
for FcyRII. Only three of the cDNAs, products of the IIa and IIa' genes, are found
in PMNs, but the principal differences appear in the signal and polyadenylation
sequences (2). In addition to the IIa and IIa' transcripts, mononuclear phagocytes
express the three transcripts ofthe IIb gene, one of which has a unique cytoplasmic
domain and a second differs only in the signal sequence (30). So the actual number
of unique receptor proteins expressed in phagocytes may not be as great as the number
of cDNAs would indicate. Whether polymorphisms of the phagocytosis-mediating
FcyRIII gene expressed in mononuclear cells exist is not yet known. Nevertheless,
it is clear from the cDNA data beginning to appear that the antireceptor mAbs used
in the experiments described herein may recognize more than a single protein.
Summary
We have evaluated the capacity ofthe three major classes of human FcyR to mediate
phagocytosis by measuring the ability ofadherent phagocytes to internalize erythro-
cytes coated with anti-FcyR mAb. Five different cell types were studied, freshly purified
monocytes, cultured monocytes, alveolar macrophages, freshly purified polymor-
phonuclear neutrophilic leukocytes, and PMNs cultured in IFN-y. FcyRI and FcyRII
on whichever cells they were expressed were capable of phagocytosing anti-FcyR
mAb-coated erythrocytes. Furthermore, FcyRIII on mononuclear phagocytes, which
appears to be a conventional integral membrane protein that spans the lipid bilayer,
was capable of phagocytosing anti-FcyRIII-coated erythrocytes. However, FcyRIII
on neutrophils, a molecule linked to the membrane by a phosphatidylinositol-glycan
moiety, although binding anti-FcyRIII-coated erythrocytes vigorously was incapable
of mounting a phagocytic response. This deficiency correlates with the limited ca-
pacity of FcyRIII on neutrophils to mediate superoxide generation and antibody-
dependent cell-mediated cytotoxicity and it may be related to the unique structural
features of FcyRIII.
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